M Izembart

740 total citations
24 papers, 503 citations indexed

About

M Izembart is a scholar working on Endocrinology, Diabetes and Metabolism, Rheumatology and Epidemiology. According to data from OpenAlex, M Izembart has authored 24 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Rheumatology and 3 papers in Epidemiology. Recurrent topics in M Izembart's work include Thyroid Disorders and Treatments (11 papers), Thyroid Cancer Diagnosis and Treatment (9 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). M Izembart is often cited by papers focused on Thyroid Disorders and Treatments (11 papers), Thyroid Cancer Diagnosis and Treatment (9 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). M Izembart collaborates with scholars based in France, Brazil and Bulgaria. M Izembart's co-authors include Jérôme Clerc, L Barritault, Alain Chevalier, Annie Gervais, Flávia Regina Souza Lima, Vivaldo Moura‐Neto, Michel Mallat, Catherine Colin, Georges Baillet and Alfred Penfornis and has published in prestigious journals such as Journal of Neuroscience, The Journal of Clinical Endocrinology & Metabolism and Clinical Chemistry.

In The Last Decade

M Izembart

18 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Izembart France 10 311 114 110 69 63 24 503
Carol M. Preissner United States 13 285 0.9× 61 0.5× 131 1.2× 99 1.4× 36 0.6× 18 563
NORIO YOSHIKAWA Japan 16 303 1.0× 99 0.9× 68 0.6× 84 1.2× 109 1.7× 44 632
A. Kelly France 11 188 0.6× 64 0.6× 118 1.1× 99 1.4× 27 0.4× 27 387
C Lane United Kingdom 14 238 0.8× 64 0.6× 58 0.5× 35 0.5× 37 0.6× 27 702
Keiichi Kamijo Japan 14 377 1.2× 37 0.3× 23 0.2× 45 0.7× 65 1.0× 34 521
J. S. Kennerdell United States 15 222 0.7× 31 0.3× 118 1.1× 100 1.4× 24 0.4× 28 665
Ryoji Kato Japan 12 116 0.4× 41 0.4× 99 0.9× 25 0.4× 75 1.2× 31 408
Koki Yamada Japan 12 52 0.2× 73 0.6× 130 1.2× 59 0.9× 38 0.6× 28 441
Stephen W. Anderson United States 10 127 0.4× 20 0.2× 117 1.1× 47 0.7× 179 2.8× 12 405
Seiji Kannuki Japan 12 95 0.3× 45 0.4× 92 0.8× 119 1.7× 14 0.2× 33 415

Countries citing papers authored by M Izembart

Since Specialization
Citations

This map shows the geographic impact of M Izembart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Izembart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Izembart more than expected).

Fields of papers citing papers by M Izembart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Izembart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Izembart. The network helps show where M Izembart may publish in the future.

Co-authorship network of co-authors of M Izembart

This figure shows the co-authorship network connecting the top 25 collaborators of M Izembart. A scholar is included among the top collaborators of M Izembart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Izembart. M Izembart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grandmaison, Geoffroy Lorin de la, et al.. (2003). Myocarditis associated with Hashimoto’s disease: a case report. International Journal of Legal Medicine. 117(6). 361–364. 14 indexed citations
2.
Lima, Flávia Regina Souza, Annie Gervais, Catherine Colin, et al.. (2001). Regulation of Microglial Development: A Novel Role for Thyroid Hormone. Journal of Neuroscience. 21(6). 2028–2038. 103 indexed citations
3.
Clerc, Jérôme, et al.. (2000). Diagnostic d’une hyperthyroïdie. 2(2). 111–121. 1 indexed citations
4.
Izembart, M, et al.. (2000). Upper retropharyngeal node involvement in differentiated thyroid carcinoma demonstrated by 131I scintigraphy.. British Journal of Radiology. 73(876). 1260–1264. 14 indexed citations
5.
Jubault, V., Alfred Penfornis, F. Schillo, et al.. (2000). Sequential Occurrence of Thyroid Autoantibodies and Graves’ Disease after Immune Restoration in Severely Immunocompromised Human Immunodeficiency Virus-1-Infected Patients. The Journal of Clinical Endocrinology & Metabolism. 85(11). 4254–4257. 98 indexed citations
6.
Izembart, M, et al.. (1998). Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 25(3). 242–246. 104 indexed citations
7.
Izembart, M, et al.. (1998). Anticorps antiperoxydase: comparaison avec l'hémagglutination passive de deux techniques de dosage. Immuno-analyse & Biologie Spécialisée. 13(4). 257–260.
8.
9.
Clerc, Jérôme, M Izembart, Jean-Philippe Jaı̈s, et al.. (1995). Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity.. PubMed. 36(2). 217–23. 24 indexed citations
10.
Clerc, Jérôme, et al.. (1993). Influence of dose selection on absorbed dose profiles in radioiodine treatment of diffuse toxic goiters in patients receiving or not receiving carbimazole.. PubMed. 34(3). 387–93. 27 indexed citations
11.
Izembart, M, et al.. (1992). Retrospective evaluation of the dose received by the ovary after radioactive iodine therapy for thyroid cancer. European Journal of Nuclear Medicine and Molecular Imaging. 19(4). 243–7. 13 indexed citations
12.
Papo, T., et al.. (1992). Antithyroid hormone antibodies induced by interferon-alpha.. The Journal of Clinical Endocrinology & Metabolism. 75(6). 1484–1486. 16 indexed citations
13.
Izembart, M, et al.. (1992). [Clinical problems created by the presence of anti-T3 and anti-T4 antibodies].. PubMed. 21(14). 676–676. 1 indexed citations
14.
Izembart, M, et al.. (1989). Temporary Ovarian Failure in Thyroid Cancer Patients after Thyroid Remnant Ablation with Radioactive Iodine. The Journal of Clinical Endocrinology & Metabolism. 69(1). 186–190. 68 indexed citations
15.
Izembart, M, María Sala, L Baldet, Martin Schlumberger, & G Deltour. (1989). Multi-center study of a new technique for measuring free thyroxin in serum.. Clinical Chemistry. 35(10). 2137–2139. 2 indexed citations
16.
Peeters, Marc, et al.. (1988). [Thyroid function and trisomy 21. TSH increase and rT3 deficiency].. PubMed. 31(3). 137–43. 3 indexed citations
17.
Izembart, M, et al.. (1987). Dosages ultrasensibles ? à propos de la TSH. 2(1). 30–31.
18.
Crémoux, Patricia de, et al.. (1985). Serum thyroglobulin levels in hypofunctioning nodules before and after surgery. Journal of Molecular Medicine. 63(20). 1052–1054. 1 indexed citations
19.
Izembart, M, et al.. (1983). [Thyroglobulinemia in thyroid pathology].. PubMed. 41(1). 7–12. 1 indexed citations
20.
Izembart, M, et al.. (1982). [Incidence of antithyroglobulin and antimicrosomal antibodies in thyroid pathology].. PubMed. 40(6). 651–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carol M. Preissner Breakdown of academic impact, for papers by NORIO YOSHIKAWA Breakdown of academic impact, for papers by A. Kelly Breakdown of academic impact, for papers by C Lane Breakdown of academic impact, for papers by Keiichi Kamijo Breakdown of academic impact, for papers by J. S. Kennerdell Breakdown of academic impact, for papers by Ryoji Kato Breakdown of academic impact, for papers by Koki Yamada Breakdown of academic impact, for papers by Stephen W. Anderson Breakdown of academic impact, for papers by Seiji Kannuki
Rankless by CCL
2026